Sequoia Capital China Venture Fund V Overview
- Fund Strategy
-
Venture
- Fund Status
-
Closed
- Fund Manager
- Sequoia Capital
- (You're viewing 1 of 2)
- Size
-
- Vintage
-
2014
- Dry Powder
-
Sequoia Capital China Venture Fund V General Information
Description
Sequoia Capital China Venture Fund V is a venture capital fund co-managed by Hongshan Capital Group and Sequoia Capital. The fund is located in Beijing, China.
Contact Information
Fund Manager's Location
- Building 3, Room 3606
- Huamao Center, Number 77 Jianguo Road, Chaoyang District
- Beijing
- China
Sequoia Capital China Venture Fund V Investments (4)
Sequoia Capital China Venture Fund V has made a total of 4 investments. Its most recent deal was a with Brii Biosciences for . The deal was made on 20-Dec-2018.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Brii Biosciences | 20-Dec-2018 | Drug Discovery | Clinical Trials - General | |||
| OneMena | 01-Dec-2017 | Application Software | Startup | |||
| Vivace Therapeutics | 28-Jun-2017 | Early Stage VC (Series B) | Drug Discovery | Clinical Trials - Phase 1 | ||
| Whale Imaging | 28-Jul-2015 | Later Stage VC | Diagnostic Equipment | Generating Revenue |
Sequoia Capital China Venture Fund V Investment Strategy
Sequoia Capital China Venture Fund V Limited Partners (29)
Andra AP-fonden is one of Sequoia Capital China Venture Fund V’s 29 limited partners. Its latest Original was on 31-Dec-2014.
| Limited Partner Name | Type | Status | Commitment | Date | Commitment Type |
|---|---|---|---|---|---|
| Andra AP-fonden | Current | 31-Dec-2014 | Original | ||
| Andrew W. Mellon Foundation | Current | 31-Dec-2014 | Original | ||
| ATP Private Equity Partners | Current | 31-Dec-2014 | Secondary | ||
| BP Master Trust for Employee Pension Plans | Current | 31-Dec-2014 | Original | ||
| Children's Hospital Corporation Pension Plan | Corporate Pension | Current | 31-Dec-2014 | Original |
Sequoia Capital China Venture Fund V Returns Data
The below charts are illustrative of the type of graphical data available to our clients and do not represent live data.
Sequoia Capital China Venture Fund V Returns History
| Period | Contribution (by all LPs) | Dry Powder | Distribution (to all LPs) | NAV | Total Fund Distr+NAV | IRR | DPI | RVPI | TVPI | Dry Powder % |
|---|
Sequoia Capital China Venture Fund V Benchmark (49)
| Fund Name | Fund Type | Vintage | IRR | Quartile | As of Date |
|---|---|---|---|---|---|
| SXE Ventures Fund | |||||
| Linear Venture USD Fund I | |||||
| Jiuding China Growth Fund II | |||||
| Source Code Fund USD I | |||||
| TIDC 2014 | |||||
| Sequoia Capital China Venture Fund V | |||||
| DCM Ventures China Turbo Fund | 31-Dec-2025 | ||||
| Top Taiwan I Venture Capital | |||||
| Top Taiwan II Venture Capital | |||||
| Top Taiwan III Venture Capital |
Sequoia Capital China Venture Fund V FAQs
-
What is Sequoia Capital China Venture Fund V?
Sequoia Capital China Venture Fund V is a venture capital fund co-managed by Hongshan Capital Group and Sequoia Capital.
-
Who manages Sequoia Capital China Venture Fund V?
Sequoia Capital China Venture Fund V is managed by Sequoia Capital and HSG (Hong Kong).
-
Where is Sequoia Capital China Venture Fund V domiciled?
Sequoia Capital China Venture Fund V is domiciled in Cayman Islands.
-
What is Sequoia Capital China Venture Fund V's size?
Sequoia Capital China Venture Fund V has a size of .
-
What type of fund is Sequoia Capital China Venture Fund V?
The fund type of Sequoia Capital China Venture Fund V is Venture.
-
What is the status of Sequoia Capital China Venture Fund V?
Sequoia Capital China Venture Fund V is closed.
-
What has Sequoia Capital China Venture Fund V invested in?
Sequoia Capital China Venture Fund V has made numerous investments in companies like Brii Biosciences, OneMena, and Vivace Therapeutics within the Drug Discovery and Application Software industries.
-
What has Sequoia Capital China Venture Fund V invested in recently?
Sequoia Capital China Venture Fund V's latest investment was on 20-Dec-2018 in Brii Biosciences, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process